Pulmonary Hypertension Association home
Pulmonary Hypertension Association
 contact us | join PHA | site map/search

Clinical Trials

Treatment Trials

10/2008 An International, Multi-Center, 12-Week, Double Blind, Randomized, Placebo-Controlled, Parallel Group Study Followed by a 12-Week Open-Label Extension Study to Assess the Efficacy, Safety, and Dose Response of UT-15C SR in Subjects With Pulmonary Hypertension

4/2008 An Open-label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

3/2008 ATHENA-1: A Randomized, Multicenter Study of Ambrisentan and Sildenafil Combination Therapy in Subjects with Pulmonary Arterial Hypertension who have Demonstrated a Sub-Optimal Response to Sildenafil

1/2008 Treatment of Pulmonary Hypertension and Sickle Cell Disease with Sildenafil Therapy (walk-PHaSST)

12/2007 ARIES-3: A Phase 3, Long-Term, Open-Label, Multicenter Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension Study

5/2007 FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)

5/2007 FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH)

5/2007 TRIUMPH I: Double Blind Placebo Controlled Clinical Investigation Into the Efficacy and Tolerability of Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension

5/2007 Combination Therapy in Pulmonary Arterial Hypertension

5/2007 The “VISION” Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertension

5/2007 COMPASS-2: Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)

10/2006 A Clinical Trial of Aspirin and Simvastatin in Pulmonary Arterial Hypertension

9/2006 A randomized, double-blind, placebo-controlled study to evaluate the short-term efficacy and safety of PRX-08066 in patients with pulmonary hypertension and chronic obstructive pulmonary disease.

Non-Treatment Trials

4/2007 Exercise Echocardiograms in Scleroderma

2/2007 Exercise Training in Pulmonary Hypertension

 


Better Business Bureau Accredited Charity bbb.org/charity Charity Navigator 4 Star Charity Rating best in america seal


The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

Questions about the site? email web@PHAssociation.org

Pulmonary Hypertension Association
801 Roeder Road, Ste. 400
Silver Spring, MD 20910

Copyright © 2008 Pulmonary Hypertension Association
Read our privacy policy.

For optimal viewing of PHAssociation.org we recommend the following:

PC : Windows running Internet Explorer 5.5 or higher
Macintosh: Internet Explorer 5.2 or higher
free download from Microsoft.com

  Macromedia Flash Player
free download from Macromedia.com
  Adobe Acrobat Reader 6.0 or higher
free download from Adobe.com
Patients Medical Caregivers Media What is PH